Literature DB >> 20089448

Benefits and risks of HPV testing in cervical cancer screening.

Philip E Castle, Hormuzd A Katki.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20089448     DOI： 10.1016/S1470-2045(09)70385-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  13 in total

1.  Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

Authors:  Fang-Hui Zhao; Margaret Jane Lin; Feng Chen; Shang-Ying Hu; Rong Zhang; Jerome L Belinson; John W Sellors; Silvia Franceschi; You-Lin Qiao; Philip E Castle
Journal:  Lancet Oncol       Date:  2010-11-11       Impact factor: 41.316

2.  Absence of human papillomavirus in patients with breast cancer in north-west China.

Authors:  Peng Chang; Ting Wang; Qing Yao; Yonggang Lv; Juliang Zhang; Wen Guo; Ling Wang; Jianghao Chen
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

3.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

4.  U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.

Authors:  Marie-Josèphe Horner; Sean F Altekruse; Zhaohui Zou; Louise Wideroff; Hormuzd A Katki; David G Stinchcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254

5.  How might HPV testing be integrated into cervical screening?

Authors:  Hormuzd A Katki; Nicolas Wentzensen
Journal:  Lancet Oncol       Date:  2011-12-14       Impact factor: 41.316

6.  An ecological analysis of the incidence of invasive squamous cell carcinoma of the cervix in Hispanic women in the United States.

Authors:  Kristy K Ward; Angelica M Roncancio; Miguel Angel Cano; Steven C Plaxe
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

7.  A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study.

Authors:  Randy L Carter; Le Kang; Kathleen M Darcy; James Kauderer; Shu-Yuan Liao; William H Rodgers; Joan L Walker; Heather A Lankes; S Terence Dunn; Eric J Stanbridge
Journal:  Cancer Causes Control       Date:  2012-10-17       Impact factor: 2.506

8.  An updated natural history model of cervical cancer: derivation of model parameters.

Authors:  Nicole G Campos; Emily A Burger; Stephen Sy; Monisha Sharma; Mark Schiffman; Ana Cecilia Rodriguez; Allan Hildesheim; Rolando Herrero; Jane J Kim
Journal:  Am J Epidemiol       Date:  2014-07-31       Impact factor: 4.897

9.  Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.

Authors:  Fang-Hui Zhao; Adam K Lewkowitz; Feng Chen; Margaret J Lin; Shang-Ying Hu; Xun Zhang; Qin-Jing Pan; Jun-Fei Ma; Mayineur Niyazi; Chang-Qing Li; Shu-Min Li; Jennifer S Smith; Jerome L Belinson; You-Lin Qiao; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

10.  Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.

Authors:  Paolo Giorgi Rossi; Maria Benevolo; Amina Vocaturo; Donatella Caraceni; Lucia Ciccocioppo; Antonio Frega; Irene Terrenato; Roberta Zappacosta; Deborah French; Sandra Rosini
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.